Integrated Molecular Characterization of Uterine Carcinosarcoma
Andrew D. Cherniack(Broad Institute), Mark Gerken, Julie M. Gastier‐Foster(Nationwide Children's Hospital), Juok Cho(Wellcome Sanger Institute), Hui Shen(Van Andel Institute), Ina Felau(National Cancer Institute), Noreen Dhalla(Canada's Michael Smith Genome Sciences Centre), Peter W. Laird(Van Andel Institute), Miruna Balasundaram(National Cancer Institute), Denise Brooks(University of Copenhagen), Bradley A. Murray, Reanne Bowlby(BC Cancer Agency), Lori Boice(Mayo Clinic), John A. Demchok(National Cancer Institute), Rameen Beroukhim(Broad Institute), Xin Hu(Emory University), Jay Bowen(Nationwide Children's Hospital), Sudha Chudamani, Martin L. Ferguson(National Cancer Institute), Fanny Dao(Memorial Sloan Kettering Cancer Center), Mutch David, Scott Frazer, Robert A. Soslow(Cleveland Clinic), Melissa Cline, Tom Bodenheimer(University of North Carolina at Chapel Hill), Kristian Cibulskis(Broad Institute), Rosemary E. Zuna(University of Oklahoma Health Sciences Center), Stephen B. Baylin(Johns Hopkins University), Russell R. Broaddus(University of North Carolina at Chapel Hill), Adrian Ally(The University of Texas MD Anderson Cancer Center), J. Todd Auman(The University of Texas MD Anderson Cancer Center), Stacey Gabriel(Broad Institute), Jessica Frick, Faina Bogomolniy, Raju Kucherlapati(Harvard University), Sean C. Dowdy(Mayo Clinic), Nils Gehlenborg(Harvard University), Saianand Balu(National Cancer Institute), Vonn Walter(Pennsylvania State University), Rebecca Carlsen(Leiden University Medical Center), Gordon Robertson(BC Cancer Agency), Eric Chuah(The University of Texas MD Anderson Cancer Center), Chip Stewart(Broad Institute), Shiyun Ling(Guangzhou University of Chinese Medicine), Gordon B. Mills(The University of Texas MD Anderson Cancer Center)
Cited by 449
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k